目的 探讨临床药师为慢性肾脏病(CKD)患者提供药物重整服务的模式。方法 分析国内外对药物重整的定义、工作流程、发展现状等情况,对重整出来的用药问题采用欧洲药学监护网络基金会(PCNE)对药物相关问题(DRPs)的分类版本(V9.0)进行分析并干预。结合我院实际情况,通过具体案例阐述CKD患者药物重整的工作流程,并归纳总结。结果 我院以CKD患者从门诊→住院→家3个地点变更为节点,构建了门诊→入院→出院这一闭环药物重整模式,并制定了相应的工作流程。结论 我院CKD患者药物重整模式的建立使临床药师的药学服务工作更规范,减少了DRPs。
Abstract
OBJECTIVE To develop the model of medication reconciliation (MR) service provided by clinical pharmacist for chronic kidney disease (CKD). METHODS The definition, working process, development of MR were analyzed and the medication problems we reviewed were classified and intervened according to the newest Pharmaceutical Care Network Europe (PCNE) V9.0 classification scheme which was constructed for drug related problems (DRPs) to analysis and summary. We stated and summarized procedure of MR by several cases based on the realities of our hospital. RESULTS A new closed loop model of outpatient clinic to hospital, then to home was developed, a working process was made according to three settings consist of outpatient clinic, hospital and home. CONCLUSION The procedure of MR of several cases was summarized based on the realities on our hospital.
关键词
药物重整 /
慢性肾脏病 /
工作模式 /
临床药师
{{custom_keyword}} /
Key words
medication reconciliation /
chronic kidney disease /
work model /
clinical pharmacist
{{custom_keyword}} /
中图分类号：
R952
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] ZHANG L X, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet,2012,379(9818):815-822.
[2] STPETER W L, WAZNY L D, PATEL U D. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management[J]. Curr Opin Nephrol Hypertens,2013,22(6):656-662.
[3] LE K D, LIANG Y, YANG C Q. Medication reconciliation by clinical pharmacists for patients with chronic kidney disease[J]. Chin J New Drugs(中国新药杂志),2017,26(10):1213-1218.
[4] LIU Y, CUI X L, LIU L H. Brief analysis of medication reconciliation between domestic and foreign[J]. Chin Pharm J(中国药学杂志),2015,50(24):2099-2112.
[5] YAO H J, LI P, LIU X Z, et al. Pharmaceutical care practice for admission medication reconciliation in the internal medicine inpatient by clinical pharmacists[J]. J China Pharm(中国药房),2017,28(32):4580-4584.
[6] Joint Commission on Accreditation of Healthcare Organizations. Using medication reconciliation to prevent errors[J]. Sentinel Event Alert,2006,(35):1-4.
[7] Institute for healthcare Improvement. Medication reconciliation to prevent adverse drug events[EB/OL]. [2019-12-25]. http://www.ihi.org/topics/adesmedicationreconciliation/Pages/default.aspx.
[8] LEOTSAKOS A, ZHENG H, CROTEAU R. Standardization in patient safety: the WHO high 5s project[J]. Int J Qual Health Care, 2014,25(2):109-116.
[9] ALMANASREH E, MOLES R, CHEN T F. The medication reconciliation process and classification of discrepancies: a systematic review[J]. Br J Clin Pharmacol,2016,82(3):645-658.
[10] SPLAWSKI J, MINGER H. Value of the pharmacist in the medication reconciliation process[J]. P T,2016,41(3):176-178.
[11] MEKONNEN A B, MCLACHLAN A J, BRIEN J A. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and Meta-analysis[J]. BMJ Open, 2016, 6(2):e010003.
[12] ASHP statement on the pharmacist′s role in medication reconciliation[J]. Am J Health Syst Pharm,2013,70(5):453-456.
[13] Pharmaceutical Care Network Europe Association. PCNE Classification for Drug related problems[EB/OL]. [2019-12-25]. https://www.pcne.org/working-groups/2/drug-related-problem-classification.
[14] WANG H X, ZHU X T, XIE C, et al. Primary medication reconciliation service provided by clinical pharmacist for chronic kidney disease in our hospital[J]. Chin Pharm J(中国药学杂志),2018,53(24):2148-2151.
[15] ZHU X T, HANG Y F. Clinical pharmacists′ pharmaceutical care and practice in the department of nephrology[J]. Chin J Clin Pharmacol Ther(中国临床药理学与治疗学),2018,23(10):1174-1178.
[16] WANG H X, HANG Y F. Pharmaceutical services in the department of nephrology: examples and experiences[J]. Cent South Pharm(中南药学),2019,17(4):607-609.
[17] ZIMMERMAN K M, SALGADO T M, DIXON D L. Medication reconciliation vs medication review[J]. JAMA,2017,318(10):965-966.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家临床重点专科(临床药学)建设项目资助
{{custom_fund}}
PDF(3565 KB)
